Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Torsades de pointes due to oral sitafloxacin.
Wakayama Y, Yoshimura S, Hanabusa K, Ikeda N, Miyamae N, Sumida Y. Wakayama Y, et al. Among authors: hanabusa k. Acute Med Surg. 2023 Dec 21;10(1):e910. doi: 10.1002/ams2.910. eCollection 2023 Jan-Dec. Acute Med Surg. 2023. PMID: 38130355 Free PMC article. No abstract available.
Infrapopliteal 3-Vessel Occlusive Disease Is the Only Predictor of Wound Recurrence After Complete Wound Healing via Endovascular Therapy in Patients With Chronic Limb-threatening Ischemia.
Yanagiuchi T, Kato T, Hirano K, Hanabusa K, Ota Y, Yamazaki S, Fushimura Y, Ushimaru S, Yokoi H, Zen K, Matoba S. Yanagiuchi T, et al. Among authors: hanabusa k. J Endovasc Ther. 2023 Sep 13:15266028231197983. doi: 10.1177/15266028231197983. Online ahead of print. J Endovasc Ther. 2023. PMID: 37702477
High Global Limb Anatomic Staging System Femoropopliteal Grade is Positively Associated with Wound Healing in Patients with Chronic Limb-Threatening Ischemia Undergoing Endovascular Therapy Only for Femoropopliteal Disease.
Yanagiuchi T, Kato T, Hirano K, Hanabusa K, Ota Y, Yamazaki S, Fushimura Y, Ushimaru S, Yokoi H, Zen K, Matoba S. Yanagiuchi T, et al. Among authors: hanabusa k. Ann Vasc Surg. 2023 May;92:264-271. doi: 10.1016/j.avsg.2022.11.032. Epub 2023 Jan 10. Ann Vasc Surg. 2023. PMID: 36634898
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
A model for predicting the time of early symptomatic restenosis after infrapopliteal angioplasty in patients with critical limb ischemia.
Yanagiuchi T, Kato T, Hiroe T, Yabuta J, Hanabusa K, Ota Y, Komai T, Yamazaki S, Ushimaru S, Kurimoto R, Yokoi H, Mani H, Zen K, Matoba S. Yanagiuchi T, et al. Among authors: hanabusa k. Cardiovasc Interv Ther. 2021 Jul;36(3):330-337. doi: 10.1007/s12928-020-00691-1. Epub 2020 Jul 18. Cardiovasc Interv Ther. 2021. PMID: 32683547
84 results